Columns
- All
- Advanced Degrees
- Analyze This
- Back Page
- Clinically Speaking
- Data Integrity
- Deal Discussions
- Editorial
- Emerging Markets
- Executive Perspective
- FDA Watch
- Financial Analysis
- Getting Results
- I Mak
- India Report
- Lowe Down
- Managing Your Career
- Newsmakers Interviews
- Opinions & Best Practices
- PBOA News
- Pharma Beat
- Preclinical Outsourcing
- The BioPharm Insider
-
Speeding Vaccine Development with Advanced Analytics
Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development processDr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 05.05.20
-
HCQ Comes Center Stage
Indian players ramp up chloroquine productionS. Harachand, Contributing Editor 05.05.20
-
-
Rapid Delivery of Medical Countermeasures Amid Pandemic
Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccinesKristin Brooks, Managing Editor, Contract Pharma 05.05.20
-
Information Technology | Regulatory Affairs
Data Integrity: Beyond Electronic Records
Get your Data Integrity house in orderTim Rhines, Ph.D., Director, Lachman Consultant Services, Inc. 05.05.20
-
Building Dynamic Levels of Influence
What makes a true leader in today’s modern workplace?Ryan Raver, PhD, Contributing Editor 05.05.20
-
Scientists to Stop COVID-19
Secret group of top scientists and billionaires uncovered; band together to fight COVID-19Tim Wright, Editor 05.05.20
-
APIs
SOPs to Spur Growth in API Manufacturing
CMOs see outsourcing prospects improveS. Harachand, Contributing Editor 04.01.20
-
The Supply Chain House of Cards
The COVID-19 pandemic exposes pressures on extended global supply chainsEmil W. Ciurczak, DoraMaxx Consulting 04.01.20
-
Regulatory Affairs
Inquiring Minds Want to Know, Just Ask FDA
What you need to know prior to submissionMichelle Ryder, Lachman Consultant 04.01.20
-
COVID-19 & Fear of the Unkown
We should be just as concerned with curbing the spread of fear, as we are the coronavirusTim Wright, Editor, Contract Pharma 04.01.20
-
Trends Affecting the Generic Drugs Sector in 2020
Supply chain issues, the need for additional talent chemists, lower drug prices, growth of development in the U.S. will be key factors.Ed Price, President, Seqens NA 03.04.20
-
Supply Chain
Oral Solids Makers Face Corona Heat
CDMOs fear supply disruptions, price increases.S. Harachand, Contributing Editor 03.04.20
-
Analytical Services | Laboratory Testing
The Supply Chain, as Developed by IKEA (some assembly required)
Pick One from Column A, Two from Column B, etc.Emil W. Ciurczak, DoraMaxx Consulting 03.04.20
-
Regulatory Affairs
The Art of Filing NDA/ANDA Post-Approval Changes to the FDA
Some tips to make your trip along the regulatory pathway to report manufacturing changes easier.Amy Schutte, Senior Associate, Lachman Consultant Services 03.04.20
-
Coronavirus 2020
What’s The Impact To The World and Industry?Ben Locwin, Contributing Editor 03.04.20
-
Fully Developing Your Executive Presence
Do you have the “It” factor?Ryan Raver, PhD , Contributing Editor 03.04.20
-
Coronavirus Fear Spreads
A doomsday scenario, or another outbreak that will come and go?Tim Wright, Editor 03.04.20
-
QA/QC
Quality Management: Preserving and Perpetuating Your Record
CDMOs must ensure that their top priority be delivering the highest quality products.Colleen Herczak, Vice President of Quality, Grand River Aseptic Manufacturing 01.28.20
-
Biosimilars
